Stephen hurst resigns from mindmed board of directors

New york, jan. 7, 2022 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a leading biotech company developing psychedelic-derived therapies, announces the resignation of stephen hurst from his role as a director of the company's board of directors. "on behalf of mindmed, the board of directors, and the executive team, i thank steve for his significant contributions and strategic guidance in bringing the company to this stage of development," said robert barrow, chief executive officer and director of mindmed.
MNMD Ratings Summary
MNMD Quant Ranking